Why Shares of Editas Medicine Dropped 15.5% in November

Why Shares of Editas Medicine Dropped 15.5% in November

What happened Shares of Editas Medicine (NASDAQ: EDIT), a clinical-stage biotech company, fell by 15.5% in November, according to data from S&P Global Intelligence. The stock closed October at $12.55 a share, then opened November at $13.